Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Globe Newswire • about 2 months agoCAMBRIDGE, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of...